Added to YB: 2024-03-29
Pitch date: 2024-03-28
IRIX [bullish]
IRIDEX Corporation
-68.73%
current return
Author Info
No bio for this author
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$20.2M
Pitch Price
$2.94
Price Target
6.10 (+562%)
Dividend
N/A
EV/EBITDA
-15.08
P/E
-3.93
EV/Sales
0.50
Sector
Health Care Equipment and Supplies
Category
special_situation
Iridex's Strategic Review Process Should Bear Fruit 'Soon'
IRIX: Strategic review progressing, transaction expected in Q2. Shares undervalued, retina biz worth $4.30/share (6-8x $10M est profit). Glaucoma worth $1.50/share (2-3x sales), huge potential. $0.30/share cash. My PT: $6.10 (double current), Topcon paid $6.18 in '20. Low risk, high upside.
Read full article (11 min)